tirzepatide surpass-4 The SURPASS 1-5 study as an evaluation of in monotherapy or Tirzepatide reduces albuminuria among adults
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Look AHEAD Research Group, author
Conlon, J.M., O'Harte, F.P.M., Flatt, P.R
Heart failure with preserved ejection fraction: JACC Scientific Statement
One weekly injection
Not intended for human or veterinary applications
Cardiovascular actions of incretin-based therapies
